Cary Street Partners Asset Management’s GSK GSK Stock Holding History

Cary Street Partners Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-800	Closed	-$28.5K	–	271
2023 Q1	$28.5K	Hold	800	–	–	0.01%	278
2022 Q4	$28.1K	Hold	800	–	–	0.01%	301
2022 Q3	$24K	Buy	+800	New	+$30.3K	0.01%	268

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cary Street Partners Asset Management's GSK Position: Q2 2023 in Review

Cary Street Partners Asset Management sold out of GSK (GSK) in Q2 2023, closing a stake of 800 shares — an estimated $28.5K sold.

Cary Street Partners Asset Management first reported a position in GSK in Q3 2022 and held it in 3 quarters. The position peaked at $28.5K in Q1 2023. 828 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

Cary Street Partners Asset Management reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
Cary Street Partners Asset Management sold 800 GSK shares in Q2 2023, an estimated $28.5K.
Cary Street Partners Asset Management first reported a position in GSK in Q3 2022 and held it in 3 quarters.
Cary Street Partners Asset Management's GSK position peaked at $28.5K in Q1 2023.
828 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Cary Street Partners Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.